Assessing the Bioavailability of Leading Phytonutrient Products

Epiceutical Labs

Status: Unknown

Conditions: Inflammation

Treatments: Dietary Supplement: Curcumin

Study type: Interventional

Funder types: Industry

Identifiers

NCT05349032

101

Details and patient eligibility

About

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. The study will secondarily look at inflammatory markers in the urine to determine any change.

Full description

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. 120 mg of curcumin from brands Meriva, CurcElite, Lonvida, UltraCur, NovaSol. The study will secondarily look at inflammatory markers in the urine to determine any change.

Enrollment: 15 estimated patients

Sex: Male

Ages: 21 to 49 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age and gender

Exclusion criteria

• Cannot take any phytonutrient or curcumin supplement five days prior to commencement.

Trial design

Primary purpose: Basic Science

Allocation: Non-Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

15 participants in 5 patient groups

Meriva

Other group

Description:

120 mg of curcumin in Meriva.

Treatment:

Dietary Supplement: Curcumin

Longvida

Other group

Description:

120 mg of curcumin Longvida.

Treatment:

Dietary Supplement: Curcumin

NovaSol

Other group

Description:

120 mg of curcumin NovaSol

Treatment:

Dietary Supplement: Curcumin

CurcElite

Other group

Description:

120 mg of curcumin CurcElite

Treatment:

Dietary Supplement: Curcumin

UltaCur

Other group

Description:

120 mg of curcumin Ultracur

Treatment:

Dietary Supplement: Curcumin